Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the period of November 2014, specifically dated November 17, 2014. The filing serves to announce a Special General Meeting of Shareholders scheduled for December 24, 2014, at the company's offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding corporate governance and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary change is the announcement of a shareholder meeting to elect a new external director.
Guidance, Outlook, and Corporate Actions
- Shareholder Meeting: A Special General Meeting is set for December 24, 2014, at 10:00 a.m. (Israel time).
- Director Election: The meeting will vote on the election of Israel Shamay as an external director for a three-year term.
- Voting Materials: The filing includes a Notice and Proxy Statement, proxy cards for ordinary share holders, and proxy cards for American Depositary Share (ADS) holders.
- Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Key Facts for Investor Verification
- Verify the date and location of the Special General Meeting (December 24, 2014, Petach Tikva, Israel).
- Confirm the proposal to elect Israel Shamay as an external director for a three-year term.
- Review the attached Notice and Proxy Statement (Exhibit 99.1) for specific voting procedures and quorum requirements.
- Note that this filing does not contain updated financial performance data.